Surgical site infections following colorectal cancer surgery: a randomized prospective trial comparing common and advanced antimicrobial dressing containing ionic silver

被引:38
作者
Biffi, Roberto [1 ,7 ]
Fattori, Luca [2 ]
Bertani, Emilio [3 ,4 ]
Radice, Davide [5 ]
Rotmensz, Nicole [5 ]
Misitano, Pasquale [1 ,7 ]
Cenciarelli, Sabine [1 ,7 ]
Chiappa, Antonio [3 ,4 ]
Tadini, Liliana [6 ]
Mancini, Marina [6 ]
Pesenti, Giovanni [2 ]
Andreoni, Bruno [3 ,4 ]
Nespoli, Angelo [2 ]
机构
[1] Univ Rostock, Dept Gen Thorac Vasc & Transplantat Surg, D-18057 Rostock, Germany
[2] Univ Rostock, Inst Pathol, D-18055 Rostock, Germany
[3] Univ Rostock, Dept Neurol, Neurodegenerat Res Lab NRL, D-18147 Rostock, Germany
[4] Univ Rostock, German Natl Dementia Ctr DZNE, D-18147 Rostock, Germany
[5] Univ Rostock, Inst Biostat & Informat Med & Ageing Res, D-18057 Rostock, Germany
[6] Univ Rostock, Inst Expt Surg, D-18057 Rostock, Germany
[7] European Inst Oncol, Div Abdominopelv & Minimally Invas Surg, I-43520141 Milan, Italy
关键词
Colorectal cancer; Elective surgery; Hydrofiber dressing; Ionic silver; Surgical site infection; EXPRESSION; SURVIVAL; ANTIGEN; CARCINOMA; RESECTION;
D O I
10.1186/1477-7819-10-94
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Background: An antimicrobial dressing containing ionic silver was found effective in reducing surgical-site infection in a preliminary study of colorectal cancer elective surgery. We decided to test this finding in a randomized, double-blind trial. Methods: Adults undergoing elective colorectal cancer surgery at two university-affiliated hospitals were randomly assigned to have the surgical incision dressed with Aquacel (R) Ag Hydrofiber dressing or a common dressing. To blind the patient and the nursing and medical staff to the nature of the dressing used, scrub nurses covered Aquacel (R) Ag Hydrofiber with a common wound dressing in the experimental arm, whereas a double common dressing was applied to patients of control group. The primary end-point of the study was the occurrence of any surgical-site infection within 30 days of surgery. Results: A total of 112 patients (58 in the experimental arm and 54 in the control group) qualified for primary end-point analysis. The characteristics of the patient population and their surgical procedures were similar. The overall rate of surgical-site infection was lower in the experimental group (11.1% center 1, 17.5% center 2; overall 15.5%) than in controls (14.3% center 1, 24.2% center 2, overall 20.4%), but the observed difference was not statistically significant (P = 0.451), even with respect to surgical-site infection grade 1 (superficial) versus grades 2 and 3, or grade 1 and 2 versus grade 3. Conclusions: This randomized trial did not confirm a statistically significant superiority of Aquacel (R) Ag Hydrofiber dressing in reducing surgical-site infection after elective colorectal cancer surgery.
引用
收藏
页数:15
相关论文
共 23 条
[1]
[Anonymous], 1997, TNM CLASSIFICATION M, VFifth
[2]
Mucins and mucin binding proteins in colorectal cancer [J].
Byrd, JC ;
Bresalier, RS .
CANCER AND METASTASIS REVIEWS, 2004, 23 (1-2) :77-99
[3]
Treatment in advanced colorectal cancer: what, when and how? [J].
Chau, I. ;
Cunningham, D. .
BRITISH JOURNAL OF CANCER, 2009, 100 (11) :1704-1719
[4]
COLORECTAL-CANCER - A LARGE UNSELECTED AUSTRALIAN SERIES [J].
DAVIS, NC ;
EVANS, EB ;
COHEN, JR ;
THEILE, DE ;
JOB, DM .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1987, 57 (03) :153-159
[5]
ROLE OF ANESTHESIA IN SURGICAL MORTALITY [J].
DRIPPS, RD ;
ECKENHOFF, JE ;
LAMONT, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1961, 178 (03) :261-&
[6]
Fleming TR, 2005, COUNTING PROCESSES S, P448
[7]
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer - Analysis of 1001 consecutive cases [J].
Fong, Y ;
Fortner, J ;
Sun, RL ;
Brennan, MF ;
Blumgart, LH .
ANNALS OF SURGERY, 1999, 230 (03) :309-318
[8]
Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. and Robert Koch-Institut, 2006, KREBS DEUTSCHL HAUF, P108
[9]
Grabowski P, 2000, INT J CANCER, V88, P281, DOI 10.1002/1097-0215(20001015)88:2<281::AID-IJC21>3.0.CO
[10]
2-2